hVIVO plc (LON:HVO – Get Free Report)’s share price crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of GBX 28.07 ($0.36) and traded as low as GBX 25 ($0.32). hVIVO shares last traded at GBX 25.40 ($0.32), with a volume of 2,916,822 shares changing hands.
hVIVO Price Performance
The company has a market cap of £164.11 million, a P/E ratio of 846.67 and a beta of 0.97. The stock has a 50-day simple moving average of GBX 28.07 and a 200 day simple moving average of GBX 28.11. The company has a debt-to-equity ratio of 33.86, a quick ratio of 1.16 and a current ratio of 1.61.
hVIVO Company Profile
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Recommended Stories
- Five stocks we like better than hVIVO
- Are Penny Stocks a Good Fit for Your Portfolio?
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- What is a Special Dividend?
- Applied Materials Market Capitulates: Now is the Time to Buy
- Compound Interest and Why It Matters When Investing
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
